Amicus Therapeutics, Inc.' CEO John F. Crowley to Advocate for Rare and Orphan Disease Community in Washington, D.C. This Week

Published: Sep 11, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CRANBURY, N.J., Sept. 11, 2013 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD) today announced that John F. Crowley, Chairman and Chief Executive Officer, will advocate for the rare and orphan disease community at several upcoming events in Washington, D.C tomorrow on September 12, 2013:

Help employers find you! Check out all the jobs and post your resume.

Back to news